Literature DB >> 27080914

[German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging].

Henryk Barthel1, Philipp T Meyer, Alexander Drzezga, Peter Bartenstein, Henning Boecker, Peter Brust, Ralph Buchert, Heinz H Coenen, Christian la Fougère, Gerhard Gründer, Frank Grünwald, Bernd J Krause, Torsten Kuwert, Matthias Schreckenberger, Klaus Tatsch, Karl-Josef Langen, Osama Sabri.   

Abstract

Recently, a number of positron emission tomography (PET) radiotracers have been approved for clinical use. These tracers target cerebral beta-amyloid (Aβ) plaques, a hallmark of Alzheimer's disease. Increasing use of this method implies the need for respective standards. This German Society of Nuclear Medicine guideline describes adequate procedures for Aβ plaque PET imaging. It not only discusses the tracers used for that purpose, but also lists measures for correct patient preparation, image data generation, processing, analysis and interpretation. With that, this "S1" category (according to the German Association of the Scientific Medical Societies standard) guideline aims at contributing to quality assurance of nuclear imaging in Germany.

Entities:  

Keywords:  Beta-amyloid; PET; guideline; plaques; positron emission tomography

Mesh:

Substances:

Year:  2016        PMID: 27080914     DOI: 10.3413/Nukmed-0816-16-04

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  2 in total

1.  Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)-study protocol for a randomized controlled trial.

Authors:  Miranka Wirth; Claudia Schwarz; Gloria Benson; Nora Horn; Ralph Buchert; Catharina Lange; Theresa Köbe; Stefan Hetzer; Marta Maglione; Eva Michael; Stefanie Märschenz; Knut Mai; Ute Kopp; Dietmar Schmitz; Ulrike Grittner; Stephan J Sigrist; Slaven Stekovic; Frank Madeo; Agnes Flöel
Journal:  Alzheimers Res Ther       Date:  2019-05-01       Impact factor: 6.982

2.  Clinical Relevance of [18F]Florbetaben and [18F]FDG PET/CT Imaging on the Management of Patients with Dementia.

Authors:  Damiano Librizzi; Nicole Cabanel; Maxim Zavorotnyy; Elisabeth Riehl; Tilo Kircher; Markus Luster; Behrooz Hooshyar Yousefi
Journal:  Molecules       Date:  2021-02-26       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.